0001140361-17-024576.txt : 20170609
0001140361-17-024576.hdr.sgml : 20170609
20170609161633
ACCESSION NUMBER: 0001140361-17-024576
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
EFFECTIVENESS DATE: 20170609
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALZHEON, INC.
CENTRAL INDEX KEY: 0001582636
IRS NUMBER: 463074149
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-288477
FILM NUMBER: 17903126
BUSINESS ADDRESS:
STREET 1: 111 SPEEN STREET
STREET 2: SUITE 306
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
BUSINESS PHONE: 857-214-7242
MAIL ADDRESS:
STREET 1: 111 SPEEN STREET
STREET 2: SUITE 306
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
D
1
primary_doc.xml
X0707
D
LIVE
0001582636
ALZHEON, INC.
111 Speen Street
Suite 306
Framingham
MA
MASSACHUSETTS
01701
508-861-7709
DELAWARE
None
None
Corporation
true
2013
David
Nikodem
111 Speen Street
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Director
Scott
Minick
111 Speen Street
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Director
Martin
Tolar
111 Speen Street
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Director
Franz
Hefti
111 Speen Street
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Director
Dennis
Langer
111 Speen St
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Director
Jean-Pierre
Garnier
111 Speen St
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Director
Ken
Mace
111 Speen St
Suite 306
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2017-05-25
false
true
false
0
CIM Securities, LLC
None
None
120852
509 Madison Avenue
Suite 906
New York
NY
NEW YORK
10022
CA
CALIFORNIA
CO
COLORADO
DE
DELAWARE
FL
FLORIDA
IL
ILLINOIS
MA
MASSACHUSETTS
MD
MARYLAND
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
WY
WYOMING
false
15764099
15764099
0
Total Offering Amount and Total Amount Sold also include the conversion of Promissory Notes.
false
63
163106
0
0
false
ALZHEON, INC.
/s/ Martin Tolar
Martin Tolar
Chief Executive Officer
2017-06-09